{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:37:35Z","timestamp":1792791455159,"version":"4.5.0"},"reference-count":208,"publisher":"Georg Thieme Verlag KG","issue":"09","funder":[{"name":"Bundesministerium f\u00fcr Forschung, Technologie und Raumfahrt","award":["031L0084"],"award-info":[{"award-number":["031L0084"]}],"id":[{"id":"https:\/\/ror.org\/04pz7b180","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Deutsche Forschungsgemeinschaft","award":["SCHN 947\/4-2,STR 1570\/2-1; #532010140"],"award-info":[{"award-number":["SCHN 947\/4-2,STR 1570\/2-1; #532010140"]}],"id":[{"id":"https:\/\/ror.org\/018mejw64","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Justus Liebig Universit\u00e4t Gie\u00dfen","award":["JLU-CAREER"],"award-info":[{"award-number":["JLU-CAREER"]}],"id":[{"id":"https:\/\/ror.org\/033eqas34","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Von-Behring-R\u00f6ntgen-Stiftung","award":["#72-0043"],"award-info":[{"award-number":["#72-0043"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Z Gastroenterol"],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common chronic liver disease and a major hepatic manifestation of metabolic syndrome. It is closely linked to obesity and type 2 diabetes mellitus. While many patients display a steatotic liver, some progress to steatohepatitis, fibrosis, and cirrhosis, increasing the risk of hepatocellular carcinoma (HCC). Current management targets metabolic risk factors. Metabolic and bariatric surgery (MBS) has therefore emerged as both an obesity treatment and a therapeutic option for MASLD. This narrative review summarizes evidence on clinical outcomes, efficacy, and mechanisms. Histology-based studies show MASLD resolution and relevant fibrosis regression after MBS, with durable benefits. Comparative studies indicate superiority over lifestyle intervention and conservative treatment, while direct comparisons with modern drugs (e.g. GLP-1 agonists) remain limited. Mechanistic studies suggest that MASLD remission by MBS is driven through a combination of sustained weight loss and surgery-specific effects on hepatic lipid metabolism, mitochondrial function, glucose metabolism, incretin and bile acid signalling, adipose tissue biology, and the gut-liver axis. Emerging evidence suggests fewer liver-related events and lower HCC incidence, with potential benefits in selected high-risk patients. In conclusion, MBS is not merely a weight loss intervention, but a disease-modifying, multi-system metabolic therapy with direct hepatic effects.<\/jats:p>","DOI":"10.1055\/a-2927-4771","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T22:31:01Z","timestamp":1790202661000},"page":"1291-1312","source":"Crossref","is-referenced-by-count":0,"title":["Metabolic and Bariatric Surgery as a Therapeutic Option for MASLD: Outcome, Mechanism, and Long-Term Implications"],"prefix":"10.1055","volume":"64","author":[{"given":"Martin","family":"Reichert","sequence":"first","affiliation":[{"name":"Justus-Liebig-University Giessen, HE, Germany","place":["Giessen"]},{"name":"University Hospital Giessen, HE, Germany","place":["Giessen"],"department":["General, Visceral, Thoracic, and Transplantation Surgery"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moritz J.","family":"Strowitzki","sequence":"first","affiliation":[{"name":"Justus-Liebig-University Giessen, HE, Germany","place":["Giessen"]},{"name":"University Hospital Giessen, HE, Germany","place":["Giessen"],"department":["General, Visceral, Thoracic, and Transplantation Surgery"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Tuffs","sequence":"additional","affiliation":[{"name":"Justus-Liebig-University Giessen, HE, Germany","place":["Giessen"]},{"name":"University Hospital Giessen, HE, Germany","place":["Giessen"],"department":["General, Visceral, Thoracic, and Transplantation Surgery"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anca Laura","family":"Amati","sequence":"additional","affiliation":[{"name":"Justus-Liebig-University Giessen, HE, Germany","place":["Giessen"]},{"name":"University Hospital Giessen, HE, Germany","place":["Giessen"],"department":["General, Visceral, Thoracic, and Transplantation Surgery"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniar","family":"Amin","sequence":"additional","affiliation":[{"name":"Justus-Liebig-University Giessen, HE, Germany","place":["Giessen"]},{"name":"University Hospital Giessen, HE, Germany","place":["Giessen"],"department":["General, Visceral, Thoracic, and Transplantation Surgery"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonali","family":"Raj","sequence":"additional","affiliation":[{"name":"Justus-Liebig-University Giessen, HE, Germany","place":["Giessen"]},{"name":"University Hospital Giessen, HE, Germany","place":["Giessen"],"department":["General, Visceral, Thoracic, and Transplantation Surgery"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thilo","family":"Sprenger","sequence":"additional","affiliation":[{"name":"Department for Bariatric and Metabolic Surgery Recklinghausen, HE, Germany","place":["Recklinghausen"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Hecker","sequence":"additional","affiliation":[{"name":"Justus-Liebig-University Giessen, HE, Germany","place":["Giessen"]},{"name":"University Hospital Giessen, HE, Germany","place":["Giessen"],"department":["General, Visceral, Thoracic, and Transplantation Surgery"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Schneider","sequence":"additional","affiliation":[{"name":"Justus-Liebig-University Giessen, HE, Germany","place":["Giessen"]},{"name":"University Hospital Giessen, HE, Germany","place":["Giessen"],"department":["General, Visceral, Thoracic, and Transplantation Surgery"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2026,9,23]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.3350\/cmh.2024.0431","article-title":"Epidemiology of metabolic dysfunction-associated steatotic liver disease","volume":"31","author":"ZM Younossi","year":"2025","journal-title":"Clin Mol Hepatol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.jhep.2024.04.031","article-title":"EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)","volume":"81","author":"European Association for the Study of the L, European Association for the Study of D, European Association for the Study of O","year":"2024","journal-title":"J Hepatol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1053\/j.gastro.2025.02.044","article-title":"Global Consensus Recommendations for Metabolic Dysfunction-Associated Steatotic Liver Disease and Steatohepatitis","volume":"169","author":"ZM Younossi","year":"2025","journal-title":"Gastroenterology"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1055\/a-2309-6052","article-title":"Amendment \u201eNeue Nomenklatur zur MASLD (Metabolic Dysfunction Associated Steatotic Liver Disease; metabolische Dysfunktion assoziierte steatotische Lebererkrankung)\u201c zur S2k-Leitlinie \u201eNicht-alkoholische Fettlebererkrankung\u201c (v.2.0\/April 2022) der Deutschen Gesellschaft f\u00fcr Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS)","volume":"62","author":"E Roeb","year":"2024","journal-title":"Z Gastroenterol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"404","DOI":"10.20524\/aog.2021.0604","article-title":"Epidemiology of nonalcoholic fatty liver disease in Europe: a systematic review and meta-analysis","volume":"34","author":"E Cholongitas","year":"2021","journal-title":"Ann Gastroenterol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.jhep.2018.05.036","article-title":"Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016\u20132030","volume":"69","author":"C Estes","year":"2018","journal-title":"J Hepatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2020.100168","article-title":"The Fatty Liver Assessment in Germany (FLAG) cohort study identifies large heterogeneity in NAFLD care","volume":"2","author":"WP Hofmann","year":"2020","journal-title":"JHEP Rep"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ejim.2023.11.005","article-title":"Natural history of metabolic dysfunction-associated steatotic liver disease","volume":"122","author":"V Lekakis","year":"2024","journal-title":"Eur J Intern Med"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1053\/j.gastro.2015.04.043","article-title":"Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease","volume":"149","author":"P Angulo","year":"2015","journal-title":"Gastroenterology"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/1942648","article-title":"Steatohepatitis Is Not Associated with an Increased Risk for Fibrosis Progression in Nonalcoholic Fatty Liver Disease","volume":"2018","author":"H Hagstrom","year":"2018","journal-title":"Gastroenterol Res Pract"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000001617","article-title":"Predictors of fibrosis, clinical events and mortality in MASLD: Data from the Global-MASLD study","author":"ZM Younossi","year":"2025","journal-title":"Hepatology"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/S2213-8587(24)00318-8","article-title":"Metabolic dysfunction-associated steatotic liver disease: heterogeneous pathomechanisms and effectiveness of metabolism-based treatment","volume":"13","author":"N Stefan","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"SL Friedman","year":"2018","journal-title":"Nat Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2023.110684","article-title":"Hepatocellular carcinoma in a large cohort of type 2 diabetes patients","volume":"200","author":"CB Giorda","year":"2023","journal-title":"Diabetes Res Clin Pract"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.jhep.2019.06.021","article-title":"The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis","volume":"71","author":"ZM Younossi","year":"2019","journal-title":"J Hepatol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/S2468-1253(21)00020-0","article-title":"Non-alcoholic fatty liver disease: a multisystem disease requiring a multidisciplinary and holistic approach","volume":"6","author":"G Targher","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"452","DOI":"10.4254\/wjh.v16.i3.452","article-title":"Update in lean metabolic dysfunction-associated steatotic liver disease","volume":"16","author":"K Sato-Espinoza","year":"2024","journal-title":"World J Hepatol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgast-2020-000535","article-title":"Prevalence, risk factors and metabolic profile of the non-obese and obese non-alcoholic fatty liver disease in a rural community of South Asia","volume":"7","author":"MM Rahman","year":"2020","journal-title":"BMJ Open Gastroenterol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/ng.2901","article-title":"Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease","volume":"46","author":"J Kozlitina","year":"2014","journal-title":"Nat Genet"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1038\/ng.257","article-title":"Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease","volume":"40","author":"S Romeo","year":"2008","journal-title":"Nat Genet"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1016\/j.metabol.2015.11.008","article-title":"Histopathology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"65","author":"GT Brown","year":"2016","journal-title":"Metabolism"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1172\/JCI23621","article-title":"Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease","volume":"115","author":"KL Donnelly","year":"2005","journal-title":"J Clin Invest"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.cmet.2024.04.006","article-title":"Hepatic selective insulin resistance at the intersection of insulin signaling and metabolic dysfunction-associated steatotic liver disease","volume":"36","author":"T Bo","year":"2024","journal-title":"Cell Metab"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1194\/jlr.M081836","article-title":"Interplay between ChREBP and SREBP-1c coordinates postprandial glycolysis and lipogenesis in livers of mice","volume":"59","author":"AG Linden","year":"2018","journal-title":"J Lipid Res"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.plipres.2023.101238","article-title":"Lipidomics in pathogenesis, progression and treatment of nonalcoholic steatohepatitis (NASH): Recent advances","volume":"91","author":"G Musso","year":"2023","journal-title":"Prog Lipid Res"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2020.101134","article-title":"Mitochondrial oxidative function in NAFLD: Friend or foe?","volume":"50","author":"M Shum","year":"2021","journal-title":"Mol Metab"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.freeradbiomed.2020.02.025","article-title":"Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease","volume":"152","author":"Z Chen","year":"2020","journal-title":"Free Radic Biol Med"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23137280","article-title":"Mitochondrial Dysfunction Plays Central Role in Nonalcoholic Fatty Liver Disease","volume":"23","author":"R Ramanathan","year":"2022","journal-title":"Int J Mol Sci"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1016\/j.ajpath.2023.08.007","article-title":"The Role of Endoplasmic Reticulum in Lipotoxicity during Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Pathogenesis","volume":"193","author":"N Venkatesan","year":"2023","journal-title":"Am J Pathol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1097\/HC9.0000000000000434","article-title":"An overview of the cholesterol metabolism and its proinflammatory role in the development of MASLD","volume":"8","author":"L Zhang","year":"2024","journal-title":"Hepatol Commun"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1569915","article-title":"The microenvironment in the development of MASLD-MASH-HCC and associated therapeutic in MASH-HCC","volume":"16","author":"Q Wu","year":"2025","journal-title":"Front Immunol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines14010151","article-title":"The Role of Kupffer Cells and Liver Macrophages in the Pathogenesis of Metabolic Dysfunction-Associated Steatotic Liver Disease","volume":"14","author":"I Tsomidis","year":"2026","journal-title":"Biomedicines"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1097\/HEP.0000000000001098","article-title":"TREM2 macrophages mediate the beneficial effects of bariatric surgery against MASH","volume":"81","author":"G Fredrickson","year":"2025","journal-title":"Hepatology"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2405746121","article-title":"Lipid-associated macrophages' promotion of fibrosis resolution during MASH regression requires TREM2","volume":"121","author":"S Ganguly","year":"2024","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1038\/s43587-026-01101-6","article-title":"p21(+)TREM2(+) senescent macrophages fuel inflammaging and metabolic dysfunction-associated steatotic liver disease","volume":"6","author":"IA Salladay-Perez","year":"2026","journal-title":"Nat Aging"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2019.104364","article-title":"Hypoxia-adaptive pathways: A pharmacological target in fibrotic disease?","volume":"147","author":"MJ Strowitzki","year":"2019","journal-title":"Pharmacol Res"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"2826","DOI":"10.1016\/j.ajpath.2018.08.003","article-title":"Loss of Prolyl-Hydroxylase 1 Protects against Biliary Fibrosis via Attenuated Activation of Hepatic Stellate Cells","volume":"188","author":"MJ Strowitzki","year":"2018","journal-title":"Am J Pathol"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.ajpath.2024.10.018","article-title":"Genetic Loss of HIF-Prolyl-Hydroxylase 1, but Not Pharmacological Inhibition, Mitigates Hepatic Fibrosis","volume":"195","author":"C Tuffs","year":"2025","journal-title":"Am J Pathol"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1053\/j.gastro.2019.12.054","article-title":"Adipose Tissue-Liver Cross Talk in the Control of Whole-Body Metabolism: Implications in Nonalcoholic Fatty Liver Disease","volume":"158","author":"V Azzu","year":"2020","journal-title":"Gastroenterology"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1002\/oby.23734","article-title":"Metabolic dysfunction in obesity is related to impaired suppression of fatty acid release from adipose tissue by insulin","volume":"31","author":"MW Schleh","year":"2023","journal-title":"Obesity (Silver Spring)"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"C375","DOI":"10.1152\/ajpcell.00379.2020","article-title":"Adipose tissue inflammation and metabolic dysfunction in obesity","volume":"320","author":"T Kawai","year":"2021","journal-title":"Am J Physiol Cell Physiol"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.55673","article-title":"Adipocytokines as Predictors of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Development in Type 2 Diabetes Mellitus Patients","volume":"16","author":"A Fajkic","year":"2024","journal-title":"Cureus"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"964","DOI":"10.14218\/JCTH.2025.00204","article-title":"Research Progress on Leptin in Metabolic Dysfunction-associated Fatty Liver Disease","volume":"13","author":"JL Wang","year":"2025","journal-title":"J Clin Transl Hepatol"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1056\/NEJMra2500106","article-title":"GLP-1 Receptor Agonists","volume":"394","author":"CJ Rosen","year":"2026","journal-title":"N Engl J Med"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2026.03.011","article-title":"The weight-loss-independent hepatoprotective benefits of semaglutide are orchestrated by intrahepatic sinusoidal endothelial GLP-1 receptors","author":"MJ Gonzalez-Rellan","year":"2026","journal-title":"Cell Metab"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1111\/dom.70624","article-title":"Incretin and Glucagon Signalling in MASLD and MASH: Integrating Metabolic Pathways With Disease Progression","author":"EE Tsakiridis","year":"2026","journal-title":"Diabetes Obes Metab"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/s41575-025-01089-1","article-title":"Gut microbiome in metabolic dysfunction-associated steatotic liver disease and associated hepatocellular carcinoma","volume":"22","author":"HC Lau","year":"2025","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2024.155952","article-title":"The lipopolysaccharide-TLR4 axis regulates hepatic glutaminase 1 expression promoting liver ammonia build-up as steatotic liver disease progresses to steatohepatitis","volume":"158","author":"M Mercado-Gomez","year":"2024","journal-title":"Metabolism"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1101\/2025.09.25.678670","article-title":"TLR4 promotes liver fibrosis in metabolic dysfunction-associated steatohepatitis by a mechanism independent of hepatocytes and inflammatory cells","author":"EE Altvater","year":"2025","journal-title":"bioRxiv"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abk0855","article-title":"Risk assessment with gut microbiome and metabolite markers in NAFLD development","volume":"14","author":"H Leung","year":"2022","journal-title":"Sci Transl Med"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"G554","DOI":"10.1152\/ajpgi.00223.2019","article-title":"Bile acid receptors FXR and TGR5 signaling in fatty liver diseases and therapy","volume":"318","author":"JYL Chiang","year":"2020","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1101\/gad.1083503","article-title":"Definition of a novel growth factor-dependent signal cascade for the suppression of bile acid biosynthesis","volume":"17","author":"JA Holt","year":"2003","journal-title":"Genes Dev"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.cmet.2005.09.001","article-title":"Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis","volume":"2","author":"T Inagaki","year":"2005","journal-title":"Cell Metab"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23116046","article-title":"Molecular Basis of Bile Acid-FXR-FGF15\/19 Signaling Axis","volume":"23","author":"T Katafuchi","year":"2022","journal-title":"Int J Mol Sci"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.cmet.2011.03.019","article-title":"FGF15\/19 regulates hepatic glucose metabolism by inhibiting the CREB-PGC-1alpha pathway","volume":"13","author":"MJ Potthoff","year":"2011","journal-title":"Cell Metab"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.cmet.2009.08.001","article-title":"TGR5-mediated bile acid sensing controls glucose homeostasis","volume":"10","author":"C Thomas","year":"2009","journal-title":"Cell Metab"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1136\/gutjnl-2017-314307","article-title":"Suppressed hepatic bile acid signalling despite elevated production of primary and secondary bile acids in NAFLD","volume":"67","author":"N Jiao","year":"2018","journal-title":"Gut"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1056\/NEJMoa2309000","article-title":"A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis","volume":"390","author":"SA Harrison","year":"2024","journal-title":"N Engl J Med"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1055\/a-2769-2397","article-title":"Amendment \u201cResmetirom\u201d to the S2k guideline \u201cMetabolic Liver Diseases\u201d (formerly \u201cNon-Alcoholic Fatty Liver Disease\u201d v.2.0\/April 2022) of the German Society for Gastroenterology, Digestive and Metabolic Diseases (DGVS) (Version 2.3)","volume":"64","author":"E Roeb","year":"2026","journal-title":"Z Gastroenterol"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1056\/NEJMoa2413258","article-title":"Phase 3 Trial of Semaglutide in Metabolic Dysfunction-Associated Steatohepatitis","volume":"392","author":"AJ Sanyal","year":"2025","journal-title":"N Engl J Med"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1056\/NEJMoa2401943","article-title":"Tirzepatide for Metabolic Dysfunction-Associated Steatohepatitis with Liver Fibrosis","volume":"391","author":"R Loomba","year":"2024","journal-title":"N Engl J Med"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1056\/NEJMoa2401755","article-title":"A Phase 2 Randomized Trial of Survodutide in MASH and Fibrosis","volume":"391","author":"AJ Sanyal","year":"2024","journal-title":"N Engl J Med"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1038\/s41591-024-03018-2","article-title":"Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial","volume":"30","author":"AJ Sanyal","year":"2024","journal-title":"Nat Med"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S2213-8587(24)00316-4","article-title":"Definition and diagnostic criteria of clinical obesity","volume":"13","author":"F Rubino","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/j.soard.2024.05.009","article-title":"Scientific evidence for the updated guidelines on indications for metabolic and bariatric surgery (IFSO\/ASMBS)","volume":"20","author":"M De Luca","year":"2024","journal-title":"Surg Obes Relat Dis"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"705","DOI":"10.3238\/arztebl.2018.0705","article-title":"Obesity Surgery and the Treatment of Metabolic Diseases","volume":"115","author":"A Dietrich","year":"2018","journal-title":"Dtsch Arztebl Int"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1007\/s11695-024-07118-3","article-title":"IFSO Worldwide Survey 2020\u20132021: Current Trends for Bariatric and Metabolic Procedures","volume":"34","author":"L Angrisani","year":"2024","journal-title":"Obes Surg"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1038\/oby.2005.140","article-title":"Roux-en-Y gastric bypass improves liver histology in patients with non-alcoholic fatty liver disease","volume":"13","author":"JM Clark","year":"2005","journal-title":"Obes Res"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1381\/096089206776116462","article-title":"Roux-en-Y gastric bypass improves the nonalcoholic steatohepatitis (NASH) of morbid obesity","volume":"16","author":"SR de Almeida","year":"2006","journal-title":"Obes Surg"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/sj.ijo.0800571","article-title":"Liver abnormalities in severely obese subjects: effect of drastic weight loss after gastroplasty","volume":"22","author":"FH Luyckx","year":"1998","journal-title":"Int J Obes Relat Metab Disord"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1002\/hep.20251","article-title":"Nonalcoholic fatty liver disease: Improvement in liver histological analysis with weight loss","volume":"39","author":"JB Dixon","year":"2004","journal-title":"Hepatology"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s11605-014-2678-y","article-title":"Bariatric surgery improves histological features of nonalcoholic fatty liver disease and liver fibrosis","volume":"19","author":"AA Taitano","year":"2015","journal-title":"J Gastrointest Surg"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1111\/j.1440-1746.2007.04833.x","article-title":"Effects of bariatric surgery on nonalcoholic fatty liver disease: preliminary findings after 2 years","volume":"22","author":"CK Furuya Jr","year":"2007","journal-title":"J Gastroenterol Hepatol"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/j.jhep.2009.06.016","article-title":"Effects of weight loss induced by bariatric surgery on hepatic adipocytokine expression","volume":"51","author":"AR Moschen","year":"2009","journal-title":"J Hepatol"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1053\/j.gastro.2009.04.052","article-title":"Prospective study of the long-term effects of bariatric surgery on liver injury in patients without advanced disease","volume":"137","author":"P Mathurin","year":"2009","journal-title":"Gastroenterology"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.soard.2023.10.015","article-title":"Remission of nonalcoholic steatohepatitis after bariatric surgery: a single referral center cohort study","volume":"20","author":"C Drai","year":"2024","journal-title":"Surg Obes Relat Dis"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1097\/SLA.0000000000000945","article-title":"Roux-en-Y gastric bypass versus adjustable gastric banding to reduce nonalcoholic fatty liver disease: a 5-year controlled longitudinal study","volume":"260","author":"R Caiazzo","year":"2014","journal-title":"Ann Surg"},{"key":"ref78","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1016\/j.soard.2018.06.007","article-title":"In nonalcoholic fatty liver disease, Roux-en-Y gastric bypass improves liver histology while persistent disease is associated with lower improvements in waist circumference and glycemic control","volume":"14","author":"KJP Schwenger","year":"2018","journal-title":"Surg Obes Relat Dis"},{"key":"ref79","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1159\/000200499","article-title":"Regression of liver steatosis following gastroplasty or gastric bypass for morbid obesity","volume":"47","author":"I Ranlov","year":"1990","journal-title":"Digestion"},{"key":"ref80","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.surg.2003.10.003","article-title":"Effects of surgical treatment of the metabolic syndrome on liver fibrosis and cirrhosis","volume":"135","author":"JG Kral","year":"2004","journal-title":"Surgery"},{"key":"ref81","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.soard.2015.04.004","article-title":"Effect of Roux-en-Y gastric bypass and sleeve gastrectomy on nonalcoholic fatty liver disease: a comparative study","volume":"12","author":"D Froylich","year":"2016","journal-title":"Surg Obes Relat Dis"},{"key":"ref82","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1016\/j.soard.2015.02.006","article-title":"The effect of surgically induced weight loss on nonalcoholic fatty liver disease in morbidly obese Indians: \u201cNASHOST\u201d prospective observational trial","volume":"11","author":"P Praveen Raj","year":"2015","journal-title":"Surg Obes Relat Dis"},{"key":"ref83","doi-asserted-by":"publisher","first-page":"344","DOI":"10.3389\/fphys.2016.00344","article-title":"Roux-En Y Gastric Bypass Results in Long-Term Remission of Hepatocyte Apoptosis and Hepatic Histological Features of Non-alcoholic Steatohepatitis","volume":"7","author":"AS Schneck","year":"2016","journal-title":"Front Physiol"},{"key":"ref84","doi-asserted-by":"publisher","first-page":"8496","DOI":"10.1038\/s41598-020-65556-2","article-title":"Histological grading evaluation of non-alcoholic fatty liver disease after bariatric surgery: a retrospective and longitudinal observational cohort study","volume":"10","author":"FDM Chaim","year":"2020","journal-title":"Sci Rep"},{"key":"ref85","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1007\/s00464-020-07498-4","article-title":"Impact of laparoscopic sleeve gastrectomy on fibrosis stage in patients with child-A NASH-related cirrhosis","volume":"35","author":"MA Salman","year":"2021","journal-title":"Surg Endosc"},{"key":"ref86","doi-asserted-by":"publisher","first-page":"4022","DOI":"10.1007\/s11695-018-3466-7","article-title":"Laparoscopic Sleeve Gastrectomy Resolves NAFLD: Another Formal Indication for Bariatric Surgery?","volume":"28","author":"CM Esquivel","year":"2018","journal-title":"Obes Surg"},{"key":"ref87","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1111\/j.1572-0241.2006.00419.x","article-title":"Non-alcoholic steatohepatitis: effect of Roux-en-Y gastric bypass surgery","volume":"101","author":"KB Barker","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"ref88","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s40608-017-0168-y","article-title":"Reversal of fibrosis in patients with nonalcoholic steatohepatosis after gastric bypass surgery","volume":"4","author":"BM Parker","year":"2017","journal-title":"BMC Obes"},{"key":"ref89","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jpeds.2016.08.101","article-title":"The Benefit of Sleeve Gastrectomy in Obese Adolescents on Nonalcoholic Steatohepatitis and Hepatic Fibrosis","volume":"180","author":"M Manco","year":"2017","journal-title":"J Pediatr"},{"key":"ref90","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1007\/s00464-016-5082-8","article-title":"The effects of bariatric surgeries on nonalcoholic fatty liver disease","volume":"31","author":"T Aldoheyan","year":"2017","journal-title":"Surg Endosc"},{"key":"ref91","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1016\/j.soard.2018.07.012","article-title":"Histologic improvement of NAFLD in patients with obesity after bariatric surgery based on standardized NAS (NAFLD activity score)","volume":"14","author":"W von Schonfels","year":"2018","journal-title":"Surg Obes Relat Dis"},{"key":"ref92","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1053\/j.gastro.2020.06.006","article-title":"Bariatric Surgery Provides Long-term Resolution of Nonalcoholic Steatohepatitis and Regression of Fibrosis","volume":"159","author":"G Lassailly","year":"2020","journal-title":"Gastroenterology"},{"key":"ref93","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.1007\/s11695-020-04515-2","article-title":"Effects of Laparoscopic Sleeve Gastrectomy on Non-Alcoholic Steatohepatitis and Liver Fibrosis in Japanese Patients with Severe Obesity","volume":"30","author":"H Nikai","year":"2020","journal-title":"Obes Surg"},{"key":"ref94","doi-asserted-by":"publisher","first-page":"3839","DOI":"10.1007\/s11695-020-04722-x","article-title":"Elastic Fibers Density: a New Parameter of Improvement of NAFLD in Bariatric Surgery Patients","volume":"30","author":"C Leite","year":"2020","journal-title":"Obes Surg"},{"key":"ref95","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1210\/clinem\/dgaa892","article-title":"Insulin Resistance Is Central to Long-Term Reversal of Histologic Nonalcoholic Steatohepatitis After Metabolic Surgery","volume":"106","author":"MF Russo","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"ref96","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10173783","article-title":"Effects of Roux-en-Y Gastric Bypass and Sleeve Gastrectomy on Non-Alcoholic Fatty Liver Disease: A 12-Month Follow-Up Study with Paired Liver Biopsies","volume":"10","author":"JS Pedersen","year":"2021","journal-title":"J Clin Med"},{"key":"ref97","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000026436","article-title":"Therapeutic effects of sleeve gastrectomy for non-alcoholic steatohepatitis estimated by paired liver biopsy in morbidly obese Japanese patients","volume":"100","author":"E Murakami","year":"2021","journal-title":"Medicine (Baltimore)"},{"key":"ref98","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1097\/SLA.0000000000005631","article-title":"Gastric Bypass Resolves Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) in Low-BMI Patients: A Prospective Cohort Study","volume":"276","author":"AT Billeter","year":"2022","journal-title":"Ann Surg"},{"key":"ref99","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1016\/S0140-6736(23)00634-7","article-title":"Bariatric-metabolic surgery versus lifestyle intervention plus best medical care in non-alcoholic steatohepatitis (BRAVES): a multicentre, open-label, randomised trial","volume":"401","author":"O Verrastro","year":"2023","journal-title":"Lancet"},{"key":"ref100","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1186\/s12876-025-04482-x","article-title":"Impact of metabolic and bariatric surgery on MASLD: histological resolution and metabolic outcomes in a retrospective cohort","volume":"25","author":"R Longsomboon","year":"2025","journal-title":"BMC Gastroenterol"},{"key":"ref101","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1093\/ajcp\/104.1.23","article-title":"Regression of hepatic steatosis in morbidly obese persons after gastric bypass","volume":"104","author":"EM Silverman","year":"1995","journal-title":"Am J Clin Pathol"},{"key":"ref102","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1097\/01.sla.0000179652.07502.3f","article-title":"Surgically-induced weight loss significantly improves nonalcoholic fatty liver disease and the metabolic syndrome","volume":"242","author":"SG Mattar","year":"2005","journal-title":"Ann Surg"},{"key":"ref103","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1381\/0960892054222830","article-title":"Histological behavior of hepatic steatosis in morbidly obese patients after weight loss induced by bariatric surgery","volume":"15","author":"CC Mottin","year":"2005","journal-title":"Obes Surg"},{"key":"ref104","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1381\/0960892055002239","article-title":"Changes in liver histology accompanying massive weight loss after gastroplasty for morbid obesity","volume":"15","author":"C Stratopoulos","year":"2005","journal-title":"Obes Surg"},{"key":"ref105","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1381\/096089206776944904","article-title":"Histological findings in the liver before and after gastric bypass","volume":"16","author":"A Csendes","year":"2006","journal-title":"Obes Surg"},{"key":"ref106","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1381\/096089206778663805","article-title":"Weight loss and non-alcoholic fatty liver disease: falls in gamma-glutamyl transferase concentrations are associated with histologic improvement","volume":"16","author":"JB Dixon","year":"2006","journal-title":"Obes Surg"},{"key":"ref107","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1381\/096089206778392239","article-title":"Hepatic outcomes after jejunoileal bypass: is there a publication bias?","volume":"16","author":"NG Meinhardt","year":"2006","journal-title":"Obes Surg"},{"key":"ref108","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1053\/j.gastro.2006.02.024","article-title":"The evolution of severe steatosis after bariatric surgery is related to insulin resistance","volume":"130","author":"P Mathurin","year":"2006","journal-title":"Gastroenterology"},{"key":"ref109","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1053\/j.gastro.2006.01.042","article-title":"Gastric bypass surgery improves metabolic and hepatic abnormalities associated with nonalcoholic fatty liver disease","volume":"130","author":"S Klein","year":"2006","journal-title":"Gastroenterology"},{"key":"ref110","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1007\/s11695-007-9086-2","article-title":"Resolution of nonalcoholic steatohepatits after gastric bypass surgery","volume":"17","author":"X Liu","year":"2007","journal-title":"Obes Surg"},{"key":"ref111","doi-asserted-by":"publisher","first-page":"382","DOI":"10.4254\/wjh.v4.i12.382","article-title":"Surgically induced weight loss by gastric bypass improves non alcoholic fatty liver disease in morbid obese patients","volume":"4","author":"V Vargas","year":"2012","journal-title":"World J Hepatol"},{"key":"ref112","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1007\/s11695-011-0579-7","article-title":"Improvement of nonalcoholic fatty liver disease after bariatric surgery in morbidly obese Chinese patients","volume":"22","author":"CM Tai","year":"2012","journal-title":"Obes Surg"},{"key":"ref113","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1007\/s11695-011-0559-y","article-title":"Effect of bariatric surgery on liver fibrosis","volume":"22","author":"M Moretto","year":"2012","journal-title":"Obes Surg"},{"key":"ref114","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s10620-006-3077-3","article-title":"Nonalcoholic fatty liver disease treated by gastroplasty","volume":"51","author":"K Jaskiewicz","year":"2006","journal-title":"Dig Dis Sci"},{"key":"ref115","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s11695-020-04977-4","article-title":"Bariatric Surgery in Nonalcoholic Fatty Liver Disease (NAFLD): Impact Assessment Using Paired Liver Biopsy and Fibroscan","volume":"31","author":"L Agarwal","year":"2021","journal-title":"Obes Surg"},{"key":"ref116","doi-asserted-by":"publisher","first-page":"8037","DOI":"10.1097\/JS9.0000000000003031","article-title":"Histological response and hepatic steatosis changes in nonalcoholic fatty liver disease after bariatric surgery: results from the Base-NAFLD Cohort","volume":"111","author":"M Li","year":"2025","journal-title":"Int J Surg"},{"key":"ref117","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1381\/096089205774859290","article-title":"Duodenal switch has no detrimental effects on hepatic function and improves hepatic steatohepatitis after 6 months","volume":"15","author":"A Keshishian","year":"2005","journal-title":"Obes Surg"},{"key":"ref118","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1007\/s11605-007-0184-1","article-title":"Modified jejunoileal bypass surgery with biliary diversion for morbid obesity and changes in liver histology during follow-up","volume":"11","author":"I Fazel","year":"2007","journal-title":"J Gastrointest Surg"},{"key":"ref119","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1111\/jgh.15358","article-title":"FibroScan-aspartate aminotransferase score in an Asian cohort of non-alcoholic fatty liver disease and its utility in predicting histological resolution with bariatric surgery","volume":"36","author":"A Anand","year":"2021","journal-title":"J Gastroenterol Hepatol"},{"key":"ref120","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.soard.2017.09.005","article-title":"Utility of transient elastography (fibroscan) and impact of bariatric surgery on nonalcoholic fatty liver disease (NAFLD) in morbidly obese patients","volume":"14","author":"H Garg","year":"2018","journal-title":"Surg Obes Relat Dis"},{"key":"ref121","doi-asserted-by":"publisher","first-page":"2438","DOI":"10.1007\/s11695-022-06103-y","article-title":"Roux-en-Y Gastric Bypass as a Treatment for Hepatic Iron Overload: An Exploratory Study","volume":"32","author":"RN de Jesus","year":"2022","journal-title":"Obes Surg"},{"key":"ref122","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1002\/hep.32358","article-title":"Persistence of severe liver fibrosis despite substantial weight loss with bariatric surgery","volume":"76","author":"R Pais","year":"2022","journal-title":"Hepatology"},{"key":"ref123","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.metabol.2019.07.002","article-title":"Laparoscopic sleeve gastrectomy reverses non-alcoholic fatty liver disease modulating oxidative stress and inflammation","volume":"99","author":"N Cabre","year":"2019","journal-title":"Metabolism"},{"key":"ref124","doi-asserted-by":"publisher","first-page":"561","DOI":"10.3350\/cmh.2023.0384","article-title":"Bariatric intervention improves metabolic dysfunction-associated steatohepatitis in patients with obesity: A systematic review and meta-analysis","volume":"30","author":"J Hwang","year":"2024","journal-title":"Clin Mol Hepatol"},{"key":"ref125","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.cgh.2020.10.034","article-title":"AGA Clinical Practice Update on Bariatric Surgery in Cirrhosis: Expert Review","volume":"19","author":"H Patton","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref126","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1038\/s41591-024-03480-y","article-title":"Long-term liver outcomes after metabolic surgery in compensated cirrhosis due to metabolic dysfunction-associated steatohepatitis","volume":"31","author":"A Aminian","year":"2025","journal-title":"Nat Med"},{"key":"ref127","doi-asserted-by":"publisher","DOI":"10.3389\/fsurg.2022.986297","article-title":"Bariatric surgery in liver cirrhosis","volume":"9","author":"AS Mehdorn","year":"2022","journal-title":"Front Surg"},{"key":"ref128","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1111\/apt.16335","article-title":"Systematic review with meta-analysis: bariatric surgery reduces the incidence of hepatocellular carcinoma","volume":"53","author":"D Ramai","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"key":"ref129","doi-asserted-by":"publisher","first-page":"4449","DOI":"10.1007\/s00464-013-3127-9","article-title":"Effect of bariatric surgery on oncologic outcomes: a systematic review and meta-analysis","volume":"27","author":"MC Tee","year":"2013","journal-title":"Surg Endosc"},{"key":"ref130","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s11695-022-06350-z","article-title":"Decreased Weight Loss Following Bariatric Surgery in Patients with Type 2 Diabetes","volume":"33","author":"E Rebelos","year":"2023","journal-title":"Obes Surg"},{"key":"ref131","doi-asserted-by":"publisher","DOI":"10.1111\/dom.70617","article-title":"Weight Loss as a Determinant of Histological Improvement in Metabolic Dysfunction-Associated Steatotic Liver Disease in People With Obesity. A Systematic Review and Network Meta-Analysis of Randomised Clinical Trials","author":"M Monami","year":"2026","journal-title":"Diabetes Obes Metab"},{"key":"ref132","doi-asserted-by":"publisher","first-page":"4459","DOI":"10.1007\/s11695-024-07585-8","article-title":"Metabolic-Associated Fatty Liver Disease and Weight Loss After Bariatric Surgery: A Systematic Review and Meta-Analysis","volume":"34","author":"F Sabench","year":"2024","journal-title":"Obes Surg"},{"key":"ref133","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.soard.2024.09.012","article-title":"Endoscopic bariatric and metabolic therapies and its effect on metabolic dysfunction-associated steatotic liver disease: a review of the current literature","volume":"21","author":"V Aitharaju","year":"2025","journal-title":"Surg Obes Relat Dis"},{"key":"ref134","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1055\/a-1880-2283","article-title":"Aktualisierte S2k-Leitlinie nicht-alkoholische Fettlebererkrankung der Deutschen Gesellschaft f\u00fcr Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) \u2013 April 2022 \u2013 AWMF-Registernummer: 021\u2013025","volume":"60","author":"E Roeb","year":"2022","journal-title":"Z Gastroenterol"},{"key":"ref135","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/j.gie.2012.05.023","article-title":"Intragastric balloon significantly improves nonalcoholic fatty liver disease activity score in obese patients with nonalcoholic steatohepatitis: a pilot study","volume":"76","author":"YM Lee","year":"2012","journal-title":"Gastrointest Endosc"},{"key":"ref136","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.cgh.2020.04.068","article-title":"Intragastric Balloon Placement Induces Significant Metabolic and Histologic Improvement in Patients With Nonalcoholic Steatohepatitis","volume":"19","author":"F Bazerbachi","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref137","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1016\/j.cgh.2024.10.027","article-title":"Endoscopic Sleeve Gastroplasty Plus Lifestyle Intervention in Patients With Metabolic Dysfunction-associated Steatohepatitis: A Multicenter, Sham-controlled, Randomized Trial","volume":"23","author":"J Abad","year":"2025","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref138","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1007\/s11695-023-06668-2","article-title":"Effect of Transoral Outlet Reduction on Hepatic Fibrosis in Roux-en-Y Gastric Bypass Patients with Weight Regain and Non-alcoholic Fatty Liver Disease","volume":"33","author":"A Jaroenlapnopparat","year":"2023","journal-title":"Obes Surg"},{"key":"ref139","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1007\/s11695-024-07196-3","article-title":"Metabolic Bariatric Surgery Across the IFSO Chapters: Key Insights on the Baseline Patient Demographics, Procedure Types, and Mortality from the Eighth IFSO Global Registry Report","volume":"34","author":"WA Brown","year":"2024","journal-title":"Obes Surg"},{"key":"ref140","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1001\/jamasurg.2022.2229","article-title":"Effect of Laparoscopic Sleeve Gastrectomy vs Roux-en-Y Gastric Bypass on Weight Loss, Comorbidities, and Reflux at 10 Years in Adult Patients With Obesity: The SLEEVEPASS Randomized Clinical Trial","volume":"157","author":"P Salminen","year":"2022","journal-title":"JAMA Surg"},{"key":"ref141","doi-asserted-by":"publisher","first-page":"2762","DOI":"10.1007\/s11695-021-05412-y","article-title":"Gastric Bypass Compared with Sleeve Gastrectomy for Nonalcoholic Fatty Liver Disease: a Systematic Review and Meta-analysis","volume":"31","author":"ESMB de Brito","year":"2021","journal-title":"Obes Surg"},{"key":"ref142","doi-asserted-by":"publisher","first-page":"3681","DOI":"10.1111\/dom.70547","article-title":"Type 2 diabetes subphenotypes are associated with differential outcomes after metabolic and bariatric surgery: An international multicentre retrospective cohort study","volume":"28","author":"A Poljo","year":"2026","journal-title":"Diabetes Obes Metab"},{"key":"ref143","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1001\/jama.2021.19569","article-title":"Association of Bariatric Surgery With Major Adverse Liver and Cardiovascular Outcomes in Patients With Biopsy-Proven Nonalcoholic Steatohepatitis","volume":"326","author":"A Aminian","year":"2021","journal-title":"JAMA"},{"key":"ref144","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1002\/oby.70100","article-title":"Comparative Efficacy of Metabolic\/Bariatric Surgery Versus GLP-1 Receptor Agonists: A Network Meta-Analysis of Randomized Controlled Trials","volume":"34","author":"L Sabatella","year":"2026","journal-title":"Obesity (Silver Spring)"},{"key":"ref145","doi-asserted-by":"publisher","DOI":"10.1002\/edm2.70075","article-title":"Comparative Effectiveness of Bariatric Surgery Versus GLP-1 Receptor Agonists in Reducing the Risk of New-Onset of NASH: A Retrospective Multinational Cohort Study From North America and Europe","volume":"8","author":"A Hussein","year":"2025","journal-title":"Endocrinol Diabetes Metab"},{"key":"ref146","doi-asserted-by":"publisher","first-page":"3847","DOI":"10.1007\/s11695-025-08136-5","article-title":"Surgical Outcomes in Patients with Preoperative GLP-1 Therapy: A Retrospective Analysis","volume":"35","author":"A Poljo","year":"2025","journal-title":"Obes Surg"},{"key":"ref147","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1097\/SLA.0000000000000588","article-title":"Preoperative use of incretins is associated with increased diabetes remission after RYGB surgery among patients taking insulin: a retrospective cohort analysis","volume":"261","author":"GC Wood","year":"2015","journal-title":"Ann Surg"},{"key":"ref148","doi-asserted-by":"publisher","first-page":"741","DOI":"10.7326\/M17-2786","article-title":"Comparative Effectiveness and Safety of Bariatric Procedures for Weight Loss: A PCORnet Cohort Study","volume":"169","author":"D Arterburn","year":"2018","journal-title":"Ann Intern Med"},{"key":"ref149","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1001\/jama.2025.20301","article-title":"Combining Medications With Bariatric Surgery to Treat Obesity","volume":"335","author":"JM Morton","year":"2026","journal-title":"JAMA"},{"key":"ref150","doi-asserted-by":"publisher","DOI":"10.1093\/bjs\/znae284","article-title":"Role of obesity-management medications before and after metabolic bariatric surgery: a systematic review","volume":"111","author":"RV Cohen","year":"2024","journal-title":"Br J Surg"},{"key":"ref151","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/S2213-8587(19)30157-3","article-title":"Adjunctive liraglutide treatment in patients with persistent or recurrent type 2 diabetes after metabolic surgery (GRAVITAS): a randomised, double-blind, placebo-controlled trial","volume":"7","author":"AD Miras","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref152","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1001\/jamasurg.2023.2930","article-title":"Safety and Efficacy of Liraglutide, 3.0 mg, Once Daily vs Placebo in Patients With Poor Weight Loss Following Metabolic Surgery: The BARI-OPTIMISE Randomized Clinical Trial","volume":"158","author":"J Mok","year":"2023","journal-title":"JAMA Surg"},{"key":"ref153","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1053\/j.gastro.2015.04.005","article-title":"Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis","volume":"149","author":"E Vilar-Gomez","year":"2015","journal-title":"Gastroenterology"},{"key":"ref154","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s40618-018-0892-2","article-title":"Mechanisms underlying the weight loss effects of RYGB and SG: similar, yet different","volume":"42","author":"A Pucci","year":"2019","journal-title":"J Endocrinol Invest"},{"key":"ref155","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1002\/oby.20548","article-title":"Vertical sleeve gastrectomy reduces hepatic steatosis while increasing serum bile acids in a weight-loss-independent manner","volume":"22","author":"A Myronovych","year":"2014","journal-title":"Obesity (Silver Spring)"},{"key":"ref156","doi-asserted-by":"publisher","first-page":"2912","DOI":"10.1007\/s11695-019-03918-0","article-title":"Roux-en-Y Gastric Bypass Improves Metabolic Conditions in Association with Increased Serum Bile Acids Level and Hepatic Farnesoid X Receptor Expression in a T2DM Rat Model","volume":"29","author":"Y Yan","year":"2019","journal-title":"Obes Surg"},{"key":"ref157","doi-asserted-by":"publisher","first-page":"2960","DOI":"10.1002\/oby.23876","article-title":"Weight-independent effects of Roux-en-Y gastric bypass surgery on remission of nonalcoholic fatty liver disease in mice","volume":"31","author":"CL Axelrod","year":"2023","journal-title":"Obesity (Silver Spring)"},{"key":"ref158","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.2337\/db21-0251","article-title":"Sleeve Gastrectomy Suppresses Hepatic Glucose Production and Increases Hepatic Insulin Clearance Independent of Weight Loss","volume":"70","author":"R Ben-Haroush Schyr","year":"2021","journal-title":"Diabetes"},{"key":"ref159","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1007\/s11605-021-04908-3","article-title":"Gastric Bypass Increases Circulating Bile Acids and Activates Hepatic Farnesoid X Receptor (FXR) but Requires Intact Peroxisome Proliferator Activator Receptor Alpha (PPARalpha) Signaling to Significantly Reduce Liver Fat Content","volume":"25","author":"GS Mazzini","year":"2021","journal-title":"J Gastrointest Surg"},{"key":"ref160","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2025.5676","article-title":"Immune and metabolic remodeling following bariatric surgery: Implications for targeted immunotherapy (Review)","volume":"57","author":"Y Shao","year":"2026","journal-title":"Int J Mol Med"},{"key":"ref161","doi-asserted-by":"publisher","first-page":"2931","DOI":"10.1038\/s41467-022-30629-5","article-title":"Influence of NAFLD and bariatric surgery on hepatic and adipose tissue mitochondrial biogenesis and respiration","volume":"13","author":"JS Pedersen","year":"2022","journal-title":"Nat Commun"},{"key":"ref162","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.jpeds.2017.10.036","article-title":"Laparoscopic Sleeve Gastrectomy Improves Nonalcoholic Fatty Liver Disease-Related Liver Damage in Adolescents by Reshaping Cellular Interactions and Hepatic Adipocytokine Production","volume":"194","author":"V Nobili","year":"2018","journal-title":"J Pediatr"},{"key":"ref163","doi-asserted-by":"publisher","first-page":"4438","DOI":"10.7150\/ijbs.98362","article-title":"Multiomics analyses decipher intricate changes in the cellular and metabolic landscape of steatotic livers upon dietary restriction and sleeve gastrectomy","volume":"20","author":"S Chen","year":"2024","journal-title":"Int J Biol Sci"},{"key":"ref164","doi-asserted-by":"publisher","first-page":"129","DOI":"10.5005\/jp-journals-10018-1437","article-title":"Prevalence of Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) in Persons with Obesity and Type 2 Diabetes Mellitus: A Cross-sectional Study","volume":"14","author":"S Latif","year":"2024","journal-title":"Euroasian J Hepatogastroenterol"},{"key":"ref165","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.2337\/dci24-0094","article-title":"Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in People With Diabetes: The Need for Screening and Early Intervention. A Consensus Report of the American Diabetes Association","volume":"48","author":"K Cusi","year":"2025","journal-title":"Diabetes Care"},{"key":"ref166","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1007\/s11695-015-1834-0","article-title":"FGF 19 and Bile Acids Increase Following Roux-en-Y Gastric Bypass but Not After Medical Management in Patients with Type 2 Diabetes","volume":"26","author":"S Sachdev","year":"2016","journal-title":"Obes Surg"},{"key":"ref167","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1016\/j.soard.2023.07.005","article-title":"The role of bariatric surgery on beta-cell function and insulin resistance in patients with nonalcoholic fatty liver disease and steatohepatitis","volume":"19","author":"A Poljo","year":"2023","journal-title":"Surg Obes Relat Dis"},{"key":"ref168","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1097\/SLA.0000000000001014","article-title":"Surgical versus medical treatment of type 2 diabetes mellitus in nonseverely obese patients: a systematic review and meta-analysis","volume":"261","author":"BP Muller-Stich","year":"2015","journal-title":"Ann Surg"},{"key":"ref169","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1001\/jama.2024.0318","article-title":"Long-Term Outcomes of Medical Management vs Bariatric Surgery in Type 2 Diabetes","volume":"331","author":"AP Courcoulas","year":"2024","journal-title":"JAMA"},{"key":"ref170","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.2337\/dc21-2498","article-title":"Effect of Banded Roux-en-Y Gastric Bypass Versus Sleeve Gastrectomy on Diabetes Remission at 5 Years Among Patients With Obesity and Type 2 Diabetes: A Blinded Randomized Clinical Trial","volume":"45","author":"R Murphy","year":"2022","journal-title":"Diabetes Care"},{"key":"ref171","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1007\/s11695-010-0076-4","article-title":"Early effects of gastric banding (LGB) and of biliopancreatic diversion (BPD) on insulin sensitivity and on glucose and insulin response after OGTT","volume":"20","author":"AE Pontiroli","year":"2010","journal-title":"Obes Surg"},{"key":"ref172","doi-asserted-by":"publisher","first-page":"2683","DOI":"10.1007\/s11695-016-2157-5","article-title":"Roux-en-Y Gastric Bypass Surgery Suppresses Hepatic Gluconeogenesis and Increases Intestinal Gluconeogenesis in a T2DM Rat Model","volume":"26","author":"Y Yan","year":"2016","journal-title":"Obes Surg"},{"key":"ref173","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2022.155199","article-title":"Prandial hepatic glucose production during hypoglycemia is altered after gastric bypass surgery and sleeve gastrectomy","volume":"131","author":"M Salehi","year":"2022","journal-title":"Metabolism"},{"key":"ref174","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1053\/j.gastro.2011.05.050","article-title":"Weight-independent changes in blood glucose homeostasis after gastric bypass or vertical sleeve gastrectomy in rats","volume":"141","author":"AP Chambers","year":"2011","journal-title":"Gastroenterology"},{"key":"ref175","doi-asserted-by":"publisher","first-page":"2679","DOI":"10.1007\/s00125-013-3055-1","article-title":"Exaggerated release and preserved insulinotropic action of glucagon-like peptide-1 underlie insulin hypersecretion in glucose-tolerant individuals after Roux-en-Y gastric bypass","volume":"56","author":"C Dirksen","year":"2013","journal-title":"Diabetologia"},{"issue":"04","key":"ref176","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1007\/s00464-011-2004-7","article-title":"Gastric bypass surgery restores meal stimulation of the anorexigenic gut hormones glucagon-like peptide-1 and peptide YY independently of caloric restriction","volume":"26","author":"S Evans","year":"2012","journal-title":"Surg Endosc."},{"key":"ref177","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1097\/SLA.0000000000003614","article-title":"Effect of Sleeve Gastrectomy on Ghrelin, GLP-1, PYY, and GIP Gut Hormones: A Systematic Review and Meta-analysis","volume":"272","author":"TR McCarty","year":"2020","journal-title":"Ann Surg"},{"key":"ref178","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1007\/s11695-017-2669-7","article-title":"Predictive Value of Gut Peptides in T2D Remission: Randomized Controlled Trial Comparing Metabolic Gastric Bypass, Sleeve Gastrectomy and Greater Curvature Plication","volume":"27","author":"A Casajoana","year":"2017","journal-title":"Obes Surg"},{"key":"ref179","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0236133","article-title":"Prospective study of gut hormone and metabolic changes after laparoscopic sleeve gastrectomy and Roux-en-Y gastric bypass","volume":"15","author":"R Arakawa","year":"2020","journal-title":"PLoS One"},{"key":"ref180","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1152\/physrev.00013.2014","article-title":"Physiology of proglucagon peptides: role of glucagon and GLP-1 in health and disease","volume":"95","author":"DA Sandoval","year":"2015","journal-title":"Physiol Rev"},{"key":"ref181","doi-asserted-by":"publisher","first-page":"T1","DOI":"10.1530\/JOE-13-0414","article-title":"Effects of glucagon-like peptide 1 on appetite and body weight: focus on the CNS","volume":"221","author":"L van Bloemendaal","year":"2014","journal-title":"J Endocrinol"},{"key":"ref182","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.110270","article-title":"Gut HIF2alpha signaling is increased after VSG, and gut activation of HIF2alpha decreases weight, improves glucose, and increases GLP-1 secretion","volume":"38","author":"SS Evers","year":"2022","journal-title":"Cell Rep"},{"key":"ref183","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2024.105265","article-title":"Alterations in bile acid kinetics after bariatric surgery in patients with obesity with or without type 2 diabetes","volume":"106","author":"A Wahlstrom","year":"2024","journal-title":"EBioMedicine"},{"key":"ref184","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1038\/s41366-020-0578-7","article-title":"Bilio-enteric flow and plasma concentrations of bile acids after gastric bypass and sleeve gastrectomy","volume":"44","author":"A Eiken","year":"2020","journal-title":"Int J Obes (Lond)"},{"key":"ref185","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/nature13135","article-title":"FXR is a molecular target for the effects of vertical sleeve gastrectomy","volume":"509","author":"KK Ryan","year":"2014","journal-title":"Nature"},{"key":"ref186","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1002\/hep.28689","article-title":"Vertical sleeve gastrectomy activates GPBAR-1\/TGR5 to sustain weight loss, improve fatty liver, and remit insulin resistance in mice","volume":"64","author":"L Ding","year":"2016","journal-title":"Hepatology"},{"key":"ref187","doi-asserted-by":"publisher","DOI":"10.1111\/obr.13017","article-title":"Targeting bile acid metabolism in obesity reduction: A systematic review and meta-analysis","volume":"21","author":"SSY So","year":"2020","journal-title":"Obes Rev"},{"key":"ref188","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2020.100980","article-title":"Farnesoid X receptor contributes to body weight-independent improvements in glycemic control after Roux-en-Y gastric bypass surgery in diet-induced obese mice","volume":"37","author":"K Li","year":"2020","journal-title":"Mol Metab"},{"key":"ref189","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s11605-018-3938-z","article-title":"Concomitant PPARalpha and FXR Activation as a Putative Mechanism of NASH Improvement after Gastric Bypass Surgery: a GEO Datasets Analysis","volume":"23","author":"GS Mazzini","year":"2019","journal-title":"J Gastrointest Surg"},{"key":"ref190","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s40168-022-01264-5","article-title":"Functional changes of the gastric bypass microbiota reactivate thermogenic adipose tissue and systemic glucose control via intestinal FXR-TGR5 crosstalk in diet-induced obesity","volume":"10","author":"J Munzker","year":"2022","journal-title":"Microbiome"},{"key":"ref191","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2019388118","article-title":"Vertical sleeve gastrectomy confers metabolic improvements by reducing intestinal bile acids and lipid absorption in mice","volume":"118","author":"L Ding","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref192","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000550650","article-title":"Visceral, Not Abdominal Subcutaneous, Fat Cell Size Associates with Metabolic Dysfunction-Associated Liver Disease in Severe Obesity","author":"EJ Tremblay","year":"2026","journal-title":"Obes Facts"},{"key":"ref193","doi-asserted-by":"publisher","first-page":"12127","DOI":"10.1038\/s41598-021-91393-y","article-title":"Metabolic shift precedes the resolution of inflammation in a cohort of patients undergoing bariatric and metabolic surgery","volume":"11","author":"JR Villarreal-Calderon","year":"2021","journal-title":"Sci Rep"},{"key":"ref194","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.cmet.2018.06.004","article-title":"Time-Dependent Molecular Responses Differ between Gastric Bypass and Dieting but Are Conserved Across Species","volume":"28","author":"D Ben-Zvi","year":"2018","journal-title":"Cell Metab"},{"key":"ref195","doi-asserted-by":"publisher","first-page":"4619","DOI":"10.1210\/jc.2009-0925","article-title":"Human adipose tissue macrophages: m1 and m2 cell surface markers in subcutaneous and omental depots and after weight loss","volume":"94","author":"J Aron-Wisnewsky","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"ref196","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1055\/a-1129-6785","article-title":"Effect of Bariatric Surgery on the Circulating Level of Adiponectin, Chemerin, Plasminogen Activator Inhibitor-1, Leptin, Resistin, and Visfatin: A Systematic Review and Meta-Analysis","volume":"52","author":"M Askarpour","year":"2020","journal-title":"Horm Metab Res"},{"key":"ref197","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/s00125-015-3769-3","article-title":"Circulating leptin in non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"59","author":"SA Polyzos","year":"2016","journal-title":"Diabetologia"},{"key":"ref198","doi-asserted-by":"publisher","DOI":"10.3390\/nu16071071","article-title":"Influence of Bariatric Surgery on Gut Microbiota Composition and Its Implication on Brain and Peripheral Targets","volume":"16","author":"S Hamamah","year":"2024","journal-title":"Nutrients"},{"key":"ref199","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2024.1407555","article-title":"Bariatric-induced microbiome changes alter MASLD development in association with changes in the innate immune system","volume":"15","author":"S Shera","year":"2024","journal-title":"Front Microbiol"},{"key":"ref200","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1056\/NEJMra2412865","article-title":"Metabolic Dysfunction-Associated Steatotic Liver Disease","volume":"393","author":"G Targher","year":"2025","journal-title":"N Engl J Med"},{"key":"ref201","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1016\/j.cgh.2024.10.025","article-title":"Resolution of Metabolic Dysfunction-associated Steatohepatitis With No Worsening of Fibrosis After Bariatric Surgery Improves 15-year Survival: A Prospective Cohort Study","volume":"23","author":"G Lassailly","year":"2025","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref202","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-026-10330-z","article-title":"Genetic predictors of GLP1 receptor agonist weight loss and side effects","author":"QJ Su","year":"2026","journal-title":"Nature"},{"key":"ref203","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1001\/jamasurg.2025.3089","article-title":"Use of Glucagon-Like Peptide-1 Agonists Among Individuals Undergoing Bariatric Surgery in the US","volume":"160","author":"M Kim","year":"2025","journal-title":"JAMA Surg"},{"key":"ref204","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.soard.2019.11.013","article-title":"Bariatric procedure selection in patients with type 2 diabetes: choice between Roux-en-Y gastric bypass or sleeve gastrectomy","volume":"16","author":"A Aminian","year":"2020","journal-title":"Surg Obes Relat Dis"},{"key":"ref205","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.soard.2023.04.298","article-title":"American Society for Metabolic and Bariatric Surgery literature review on the effect of Roux-en-Y gastric bypass limb lengths on outcomes","volume":"19","author":"EM Aleassa","year":"2023","journal-title":"Surg Obes Relat Dis"},{"key":"ref206","doi-asserted-by":"publisher","first-page":"3236","DOI":"10.1007\/s11695-024-07267-5","article-title":"The Impact of Longer Biliopancreatic Limb Length on Weight Loss and Comorbidity Improvement at 5 Years After Primary Roux-en-Y Gastric Bypass Surgery: A Population-Based Matched Cohort Study","volume":"34","author":"FFE Bruinsma","year":"2024","journal-title":"Obes Surg"},{"key":"ref207","doi-asserted-by":"publisher","DOI":"10.1016\/j.soard.2026.07.016","article-title":"Biliopancreatic Limb Length Impacts Metabolic Dysfunction-Associated Steatotic Liver Diease Trajectories After Roux-En-Y Gastric Bypass","author":"C Tuffs","year":"2026","journal-title":"Accepted at Surg Obes Relat Dis"},{"key":"ref208","doi-asserted-by":"publisher","DOI":"10.1007\/s11701-026-03462-x","article-title":"Robotic versus laparoscopic Roux-en-Y gastric bypass: a propensity-matched comparison of the inflammatory response and MASLD trajectories","volume":"20","author":"C Tuffs","year":"2026","journal-title":"J Robot Surg"}],"container-title":["Zeitschrift f\u00fcr Gastroenterologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2927-4771.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T22:31:24Z","timestamp":1790202684000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2927-4771"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":208,"journal-issue":{"issue":"09","published-online":{"date-parts":[[2026,9,23]]},"published-print":{"date-parts":[[2026,9]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2927-4771","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0044-2771","1439-7803"],"issn-type":[{"value":"0044-2771","type":"print"},{"value":"1439-7803","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9]]}}}